Download FREE Report Sample
Download Free sampleRabies immunoglobulin is mainly used for passive immunization of patients bitten and scratched by rabies or other animals carrying rabies virus.
Human Rabies Immune Globulin Market contains market size and forecasts of Human Rabies Immune Globulin (HRIG) in global, including the following market information:
Global Human Rabies Immune Globulin (HRIG) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Rabies Immune Globulin (HRIG) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Rabies Immune Globulin (HRIG) companies in 2021 (%)
The global Human Rabies Immune Globulin (HRIG) market was valued at 407.5 million in 2021 and is projected to reach US$ 605.4 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
200IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Rabies Immune Globulin (HRIG) include CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio and Weiguang Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Rabies Immune Globulin (HRIG) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Rabies Immune Globulin (HRIG) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Immune Globulin (HRIG) Market Segment Percentages, by Type, 2021 (%)
200IU
500IU
Global Human Rabies Immune Globulin (HRIG) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Immune Globulin (HRIG) Market Segment Percentages, by Application, 2021 (%)
Category II Exposure
Category III Exposure
Global Human Rabies Immune Globulin (HRIG) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Immune Globulin (HRIG) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Immune Globulin (HRIG) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Rabies Immune Globulin (HRIG) revenues share in global market, 2021 (%)
Key companies Human Rabies Immune Globulin (HRIG) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Rabies Immune Globulin (HRIG) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
